|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.010 EUR | +3.35% |
|
+1.03% | +14.53% |
| 05/05 | MEDICLIN Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 04/05 | MEDICLIN Aktiengesellschaft Revises Earnings Guidance for the Year 2026 | CI |
| Market Cap | 193M 220M 178M 165M 313M 21B 317M 2.13B 827M 10.31B 827M 809M 35.75B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 193M 220M 178M 165M 313M 21B 317M 2.13B 827M 10.31B 827M 809M 35.75B | EV / Sales 2026 * |
0.24x | EV / Sales 2027 * | 0.24x |
| Free-Float |
12.27% | Yield 2026 * |
0.99% | Yield 2027 * | 0.99% |
| 1 day | +3.35% | ||
| 1 week | +1.03% | ||
| Current month | +1.03% | ||
| 1 month | -2.48% | ||
| 3 months | +17.96% | ||
| 6 months | +7.07% | ||
| Current year | +14.53% |
| 1 week | 3.84 |  | 3.94 |
| 1 month | 3.84 | | 4.18 |
| Current year | 3.26 | | 4.18 |
| 1 year | 2.84 | | 4.18 |
| 3 years | 2.2 | | 4.18 |
| 5 years | 2.2 | | 4.18 |
| 10 years | 2.2 | | 6.76 |
| Manager | Title | Age | Since |
|---|---|---|---|
Tino Marco Fritz
CEO | Chief Executive Officer | 49 | - |
Martin Buse
CMP | Compliance Officer | - | - |
Thomas Piefke
COO | Chief Operating Officer | - | 01/10/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Hans Hilpert
BRD | Director/Board Member | 60 | 01/01/2003 |
Michael Bock
BRD | Director/Board Member | 63 | 25/05/2005 |
| Director/Board Member | 63 | 20/09/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.35% | +1.03% | - | - | 220M | |
| +0.60% | -0.24% | +24.70% | +44.73% | 18.02B | |
| -0.54% | +1.67% | +15.90% | +71.52% | 13.4B | |
| -0.82% | -1.40% | -30.43% | -53.28% | 11.6B | |
| +0.50% | +6.04% | -10.12% | +62.92% | 10.61B | |
| -0.83% | +5.46% | +11.09% | +84.08% | 9.67B | |
| -1.99% | +1.55% | -2.96% | -27.71% | 9.39B | |
| -0.39% | +1.87% | +20.95% | +199.22% | 7.76B | |
| -1.42% | -2.11% | +9.32% | -21.84% | 6.97B | |
| +1.33% | +3.17% | -21.92% | - | 6.81B | |
| Average | -0.05% | +2.50% | +1.84% | +44.96% | 10.47B | |
| Weighted average by Cap. | -0.36% | +2.35% | +3.77% | +43.01% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 787M 899M 725M 673M 1.28B 85.77B 1.3B 8.68B 3.38B 42.1B 3.38B 3.3B 146B | 803M 917M 740M 687M 1.3B 87.48B 1.32B 8.86B 3.45B 42.94B 3.44B 3.37B 149B |
| Net income | 36.66M 41.86M 33.77M 31.34M 59.52M 3.99B 60.33M 404M 157M 1.96B 157M 154M 6.8B | 38.2M 43.61M 35.18M 32.65M 62.01M 4.16B 62.85M 421M 164M 2.04B 164M 160M 7.08B |
| Net Debt | - | - |
Employees
7,416
Calendar
30/07 -
Earnings release - Q2 2026
| Date | Price | Change | Volume |
|---|---|---|---|
| 07/07/26 | EUR 3.940 | +1.55% | 0 |
| 06/07/26 | EUR 3.880 | 0.00% | 0 |
| 03/07/26 | EUR 3.880 | +0.52% | 0 |
| 02/07/26 | EUR 3.860 | +0.52% | 0 |
| 01/07/26 | EUR 3.840 | -1.54% | 0 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
4.060EUR
Average target price
7.300EUR
Spread / Average Target
+79.80%
Net sales - Rate of surprise
- Stock Market
- Stocks
- MED Stock
- MED Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
